The historical rank and industry rank for Solara Active Pharma Sciences's Net Margin % or its related term are showing as below:
NSE:SOLARAPP1'
s Net Margin % Range Over the Past 10 Years
Min: -45.82 Med: 0.04 Max: 14.05
Current: -0.54
NSE:SOLARAPP1's Net Margin % is ranked worse than 67.02% of 955
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs NSE:SOLARAPP1: -0.54
Solara Active Pharma Sciences (NSE:SOLARAPP1) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Solara Active Pharma Sciences Net Margin % Related Terms
Solara Active Pharma Sciences Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SOLARAPP1 vs ZTS, UTHR: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solara Active Pharma Sciences Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Solara Active Pharma Sciences's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a Net Margin % of 2.48% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Solara Active Pharma Sciences and its competitors. This is 6100% above median its historical median of 0.04. According to the industry distribution chart, Solara Active Pharma Sciences ranks #640 out of 955 companies in the Drug Manufacturers industry, placing it in the top 67%.
Is Solara Active Pharma Sciences' Net Margin % too high?
Solara Active Pharma Sciences' current Net Margin % of 2.48% is 6100% above median its 10-year median of 0.04. The Drug Manufacturers industry median Net Margin % is 5.69. Solara Active Pharma Sciences' value of 2.48% is 56.4% below this industry median. Based on the distribution chart, Solara Active Pharma Sciences ranks #640 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Solara Active Pharma Sciences has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Solara Active Pharma Sciences ranks #640 out of 955 companies for Net Margin %. This places Solara Active Pharma Sciences in the lower half of its industry. The industry median Net Margin % is 5.69. Solara Active Pharma Sciences' value of 2.48% is 56.4% below this benchmark. While the company's 10-year median is 0.04 vs. the industry median of 5.69, Solara Active Pharma Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solara Active Pharma Sciences's current Net Margin % of 2.48% is 56.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Solara Active Pharma Sciences and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solara Active Pharma Sciences's current Net Margin % is 2.48%, which is 6100% above median its own 10-year median of 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current Net Margin % of 2.48%. The stock's GF Value™ is ₹263.62, compared to a current price of ₹267.45 — trading 1.5% above its estimated fair value. The current Net Margin % is 2.48%, which is 6100% above median its 10-year median of 0.04 and 56.4% below the Drug Manufacturers industry median of 5.69. Solara Active Pharma Sciences' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current Net Margin % is 2.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?
Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued.
The current stock price of ₹267.45 is trading 1.5% above its estimated GF Value™ of ₹263.62.
Key valuation signals for NSE:SOLARAPP1:
Net Margin %: 2.48% (6100% above median its 10-year median of 0.04)
GF Value™: ₹263.62 vs. price of ₹267.45 (1.5% above fair value)
Industry Position: 56.4% below the Drug Manufacturers median (#640 of 955)
No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Solara Active Pharma Sciences Business Description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
67GF Score
Get the complete analysis for NSE:SOLARAPP1
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOLARAPP1 has been successfully added to your 
